You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm's stock price has dropped since the announcement that the agency would need additional information and it has paused test shipments.
ZeClinics said it will use the CRISPR-Cas9 technology to create various zebrafish knockout variants for use as disease models.
Using the BRAF-V600 tumor mutation as a marker, investigators identified pre-treatment and on-treatment ties between ctDNA and patient outcomes.
Binx Health said the initial distribution of its platform will be to settings certified to perform moderate- or high-complexity diagnostic tests under CLIA.
The researchers found that 18 percent of pediatric cancer patients tested with MSK-IMPACT harbored one or more inherited risk mutation.
BioIQ will offer Fulgent's next-generation sequencing-based coronavirus assay on its diagnostic testing platform.
The company reported revenues of $627.5 million, up from $599.9 million in Q4 2019, and beating the consensus Wall Street estimate of $602.0 million.
The grant, to support the work of the GenOMICC consortium, will help to identify genetic factors associated with response to the virus.
Last week, GenomeWeb's readers were most interested in Sema4's plans to merge with and go public through a special purpose acquisition company.
One study found new risk loci for Alzheimer's disease, while the other focused on Lewy body dementia risk.
The Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit can detect and differentiate RNA from SARS-CoV-2, influenza A, and influenza B viruses.
The lab will provide researchers in the Asia-Pacific region with access to Quanterix's Simoa technology and biomarker testing, development, and validation services.
News items for the week of Feb. 8, 2021.
In December, the firm was named a finalist in a $6 million Xprize competition to develop a rapid test for detecting SARS-CoV-2.
The collaborators are requesting submissions including budget proposals to scale all supporting components of diagnostic test manufacturing.
DermTech said its gene expression-based Pigmented Lesion Assay for the early detection of melanoma is now available as an in-network option for BCBSTX members.
The PCR-based test, which is also now CE marked, provides a positive or negative result for each virus using a single specimen within three hours.
The firm's quarterly revenues beat estimates. Its full year revenues also beat estimates and were up 10 percent year over year.
The company's fourth quarter and full-year revenues of $953 million and $3.24 billion, respectively, matched estimates released last month.
The gift from philanthropists Allen and Charlotte Ginsburg will support a new center within UCLA's Institute for Precision Health and a patient clinic.
Researchers used CRISPR to reintroduce an archaic variant of NOVA1 into cortical organoids to study how a human-specific variant may have affected evolution.
Polynesian ancestry — encompassing genetic and lifestyle factors — affects obesity, type 2 diabetes, and heart failure among Native Hawaiians, a new study has found.
Using a Cas13-based method, researchers at UCSB detected eight asymptomatic cases, while a single discrepant case had low estimated viral load.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.